ClinicalTrials.Veeva

Menu

Hypotension Prediction Index in Patients Undergoing Liver Transplantation

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Unknown

Conditions

Intraoperative Hypotension

Treatments

Device: Acumen HPI-enabled EV1000 screen

Study type

Interventional

Funder types

Other

Identifiers

NCT04872504
Hypotension prediction index

Details and patient eligibility

About

A prospective, open-label and single-center study to determine whether the use of Acumen Hypotension Prediction Index software predicts the occurrence of hypotension.

Enrollment

60 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Age ≥ 20 years;
  • Scheduled liver transplantation
  • Planned pressure monitoring with an arterial line;
  • General anesthesia

Exclusion criteria

  • Contraindication for invasive blood pressure monitoring
  • End-staged renal disease
  • pre-operative MAP <65 mmHg
  • Severe heart failure
  • Severe cardiac shunt
  • Severe aortic stenosis
  • Severe atrial fibrillation

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Acumen HPI-enabled EV1000 screen
Experimental group
Description:
Acumen HPI-enabled EV1000 screen
Treatment:
Device: Acumen HPI-enabled EV1000 screen

Trial contacts and locations

1

Loading...

Central trial contact

BO HAN YEH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems